BioPharma Credit PLC Notice of Interim Results (6203I)
12 August 2019 - 4:00PM
UK Regulatory
TIDMBPCR
RNS Number : 6203I
BioPharma Credit PLC
12 August 2019
12 August 2019
BIOPHARMA CREDIT PLC
("The Company")
NOTICE OF INTERIM RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences
debt investor, will announce its audited Half Year Results for the
period ending 30 June 2019, on Wednesday 4 September 2019.
A management presentation will be held at 09:30am at Buchanan,
107 Cheapside, EC2V 6DN. A conference call facility will also be
available.
To confirm your attendance, or request conference call details,
RSVP to biopharmacredit@buchanan.uk.com.
-Ends-
Enquiries
BioPharma Credit PLC
via Link Company Matters Limited
Company Secretary
+44 (0) 1392 477 500
Buchanan
+44 (0)20 7466 5000
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NOREKLFBKVFFBBK
(END) Dow Jones Newswires
August 12, 2019 02:00 ET (06:00 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024